Drug industry CEOs angrily dispute Judge Matthew Kacsmaryk’s ruling on mifepristone. But they spent millions on the Senate Republicans who confirmed him.
Drug industry CEOs angrily dispute Judge Matthew Kacsmaryk’s ruling on mifepristone. But they spent millions on the Senate Republicans who confirmed him.